Ganagliflozin proline attenuates osteogenic dysfunction and inflammatory signaling during exposure to advanced glycation end products in murine osteoblasts
World Journal of Diabetes · 15.11.2026 · 17 (11)
DOI: 10.4239/wjd.124042 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Diabetes, online erschienen am 15.11.2026. Verfasst von Zhi-Peng Li und 13 weiteren Autor:innen. Die Arbeit nennt 46 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND Advanced glycation end products (AGEs) accumulate in diabetes, disrupt the collagen I-rich bone matrix, activate inflammatory signaling involving the receptor for AGEs (RAGE) and nuclear factor kappa B (NF-κB), and impair osteoblast function. Ganagliflozin proline (Gana Pro), a sodium-glucose cotransporter 2 inhibitor, may protect bone, but its effects on AGE-induced osteogenic dysfunction remain unclear. AIM To determine whether Gana Pro attenuates AGE-induced osteogenic dysfunction and examine associated collagen I and inflammatory signaling changes. METHODS AGE accumulation was measured by enzyme-linked immunosorbent assay. Molecular docking assessed potential AGE-collagen I interactions, and collagen I-methylglyoxal co-incubation assessed modification. AGE-treated MC3T3-E1 cells received canagliflozin or Gana Pro. Cell viability, proliferation, cell-cycle distribution, collagen I, inflammatory signaling, osteogenic markers, alkaline phosphatase activity, and mineralization were evaluated using molecular, cellular, imaging, and staining assays. Separate RAGE-knockdown experiments with phorbol 12-myristate 13-acetate (PMA) stimulation assessed pathway involvement. RESULTS Higher AGE levels were observed under 25 mmol/L glucose than under 5.5 mmol/L glucose. Exploratory docking predicted non-covalent poses of representative AGE-related molecules within a fibronectin-collagen peptide complex, while methylglyoxal increased AGE-related fluorescence in a cell-free collagen I system. Commercial AGE-bovine serum albumin (BSA) exposure was associated with reduced MC3T3-E1 viability, proliferation, collagen I, osteogenic markers, alkaline phosphatase activity, and mineralization, together with increased RAGE, p65 phosphorylation, and tumor necrosis factor alpha (TNF-α). Gana Pro, particularly at 5 μM, improved proliferation, collagen I and osteogenic marker expression, alkaline phosphatase activity, calcium deposition, and mineralization, while reducing RAGE, p65 phosphorylation, and TNF-α. Separately, RAGE knockdown reduced AGE-BSA-associated p65 phosphorylation and restored osteogenic markers, whereas PMA partially attenuated this recovery. CONCLUSION Gana Pro attenuated AGE-induced osteogenic dysfunction, accompanied by restored collagen I and reduced RAGE/NF-κB inflammatory signaling; direct pharmacological rescue is required to establish pathway mediation.
Zitieren
APA
Li, Z., Li, H., Xu, J., Liu, Y., Li, D., Wang, P., Xiang, L., Xu, S., Duan, C., Wang, S., Sun, J., Zhang, C., He, D., & Luo, C. (2026). Ganagliflozin proline attenuates osteogenic dysfunction and inflammatory signaling during exposure to advanced glycation end products in murine osteoblasts. World Journal of Diabetes, 17(11). https://doi.org/10.4239/wjd.124042
Vancouver
Li Z, Li H, Xu J, Liu Y, Li D, Wang P, et al. Ganagliflozin proline attenuates osteogenic dysfunction and inflammatory signaling during exposure to advanced glycation end products in murine osteoblasts. World Journal of Diabetes. 2026;17(11). doi:10.4239/wjd.124042
BibTeX
@article{Li2026,
author = {Li, Zhi-Peng and Li, Han and Xu, Jia-Li and Liu, Ya-Jing and Li, Dong and Wang, Peng and Xiang, Lei and Xu, Shi-Yu and Duan, Cheng-Zheng and Wang, Sheng-Xin and Sun, Jin-Ke and Zhang, Chang-Jiang and He, Dong-Juan and Luo, Cheng},
title = {Ganagliflozin proline attenuates osteogenic dysfunction and inflammatory signaling during exposure to advanced glycation end products in murine osteoblasts},
journal = {World Journal of Diabetes},
year = {2026},
volume = {17},
number = {11},
doi = {10.4239/wjd.124042}
}
EUVIMED